Clinical trial
Pro-active Fecal Calprotectin Monitoring to Improve Patient Outcomes in Ulcerative Colitis: A Prospective Randomised Control Trial
NCT03549988 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pro-active Fecal Calprotectin Monitoring to Improve Patient Outcomes in Ulcerative Colitis: A Prospective Randomised Control Trial
- Lead sponsor
- University of British Columbia
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2018
- Completion date
- December 31, 2025
- Enrollment
- 726 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis